Connect with us

Hi, what are you looking for?

Jewish Business News

World News

Stock Analyst Herb Greenberg: Gluten Free a Fad, Michael Kors’ Management Defensive

Stock_Market analyst Herb Greenberg sounded off on more than stocks, but on food fads. He said Boulder Brands’ stock was up after earnings last week because management “told a good story about the future, ” when in reality, according to Greenberg “Gluten-free is a fad for most people, besides my daughter, who has Celiac disease (and needs to eat a gluten-free diet.” One indication Greenberg pointed out that Boulder Brands wasn’t serious about “real” gluten-free is that management brushed off an analyst’s question about cross-contamination. This shows a lack of commitment to a real gluten-free diet, according to Greenberg, because those who are serious about being gluten-free need to make sure no gluten enters their food and would be concerned about cross-contamination. “Gluten-free growth is slowing … people aren’t really worried about it … This thing is going to roll over.”

Greenberg also didn’t like the way Michael Kors management behaved in their earnings conference call last week, which he called “horrendous. Management was very defensive. They said, ‘Stop looking at the quarter by quarter numbers. But then why do they give quarterly numbers?” Without mentioning Coach by name, management told analysts not to compare Kors with a certain competitor. “Peers are important, ” said Greenberg. “People are going to compare.” Greenberg had harsh words for Kors’ bossy and “defensive” management and concluded, “They don’t listen to anyone but themselves.”


Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


Now Platika joins and elite club of $10 billion plus Israeli firms.

cialis cialis satış